Dr. Michael Ray Olson, MD, PhD

Dr. Olson practices at Baptist Medical Center Jacksonville in Jacksonville, Florida, part of Baptist Health.

Dr. Olson's NPI, 1427244037, was assigned on September 18, 2007. Dr. Olson graduated from Duke University School Of Medicine in 2004. Dr. Olson holds Florida license ME104231.

Dr. Olson's primary practice is Baptist Medical Center Jacksonville, at 800 Prudential Dr, Jacksonville, FL 32207 in Duval County. The practice phone is (904) 202-2000.

Dr. Olson's primary practice is Baptist Medical Center Jacksonville in Jacksonville, Florida, part of Baptist Health. Dr. Olson is also affiliated with Baptist Medical Center Beaches. The medical group on file is Baptist MD Anderson Cancer Physicians. Dmand AI also links Dr. Olson to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Olson practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Olson's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Olson is board certified in hospice and palliative medicine by the American Board of Internal Medicine. Dmand AI has Dr. Olson's licenses on file in 4 states: Florida, California, Georgia and North Carolina.

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, lung cancer radiation, lymphoma radiation and uterine cancer radiation among the conditions Dr. Olson treats.

CMS data shows 1,676 Medicare services from Dr. Olson across 14 procedure codes in 2024, for 384 Medicare patients. Medicare paid $126,021 for them.

CMS counts 384 Medicare patients who saw Dr. Olson in 2024. The largest group is 75 to 84, with 168 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Olson's median patient age at 71, with 56% women.

In 2024, Dr. Olson wrote 143 Medicare Part D claims for 54 patients. 96% of them were for generic drugs. CMS names the drug for 89 of them, across 5 drugs with 11 or more claims each, at $726 in total drug cost. In 2023, CMS named 75 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Olson for performance year 2024, reported as part of a group. Dr. Olson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Olson as offering telehealth.

Dmand AI links 18 papers to Dr. Olson, published from 2002 to 2024. 2018 was the busiest year, with 3. The most frequent topics are Drosophila Proteins, Inhibitor of Apoptosis Proteins and Air Pollutants. Dr. Olson has published most often in J Biol Chem. Dr. Olson's most frequent co-authors are Djordje Atanackovic, MD, Albert C. Koong, MD, PhD and Isidora Y. Arzu, MD, PhD.

Dmand AI links Dr. Olson to 3 clinical trials, 2 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Meningioma, Prostatic Neoplasms and Meningeal Neoplasms.

CMS Open Payments shows 31 general payments to Dr. Olson from 11 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 84% of the total. Brainlab, Inc. paid the most, $3,075.

Dr. Olson graduated from Duke University School Of Medicine in 2004. Dr. Olson is a member of ASCO.

Dr. Olson is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.